Hong Kong Auto Components Stock News

SEHK:700
SEHK:700Interactive Media and Services

Tencent Weighs AI Gaming Push And Media Investment Against Valuation Gap

Tencent Holdings (SEHK:700) has introduced a suite of AI powered game development tools at the 2026 Game Developers Conference, targeting animation, testing, anti cheat, and automated content creation. The company is also involved as a potential financial backer in the proposed US$110b Paramount Skydance acquisition of Warner Bros. Discovery, with an emphasis on a passive investment role. These moves highlight Tencent's push to deepen AI use in its core gaming operations while seeking...
SEHK:215
SEHK:215Wireless Telecom

Hutchison Telecom (SEHK:215) Thin H1 Profit Tests Optimistic Turnaround Narratives

Hutchison Telecommunications Hong Kong Holdings (SEHK:215) posts modest FY 2025 first half profit Hutchison Telecommunications Hong Kong Holdings (SEHK:215) has released its FY 2025 first half results with revenue of HK$2,216 million and net income (excluding extra items) of HK$6 million, equal to basic EPS of HK$0.001245. The company’s half year revenue moved from HK$2,058 million in 2024 H1 to HK$2,724 million in 2024 H2 and HK$2,216 million in 2025 H1. Basic EPS shifted from a loss of...
SEHK:743
SEHK:743Basic Materials

Asia Cement China SEHK 743 Q4 Loss Tests Bullish Profitability Narratives

Asia Cement (China) Holdings (SEHK:743) has reported FY 2025 results with fourth quarter revenue of C¥1.38b and a loss of C¥60.55m, translating to EPS of C¥0.04 loss per share. The company has seen revenue move from C¥1.77b in Q4 2024 to C¥1.38b in Q4 2025, while EPS shifted from C¥0.12 per share profit to C¥0.04 loss over the same period. This frames a story in which topline pressure and a weaker bottom line keep margins in focus for investors assessing how durable the recent profitability...
SEHK:2319
SEHK:2319Food

Does China Mengniu (SEHK:2319) Impairment Shift Reveal a New Balance Between Efficiency and Shareholder Cash?

China Mengniu Dairy Company Limited was recently removed from the Hang Seng China Enterprises Index and announced plans to book RMB 2.20–2.40 billion in impairment provisions on idle production facilities and certain financial and contract assets. At the same time, the company has scheduled a March 25, 2026 board meeting to approve its 2025 annual results and consider a final dividend, underscoring a balance between addressing asset quality issues and potential cash returns to...
SEHK:3393
SEHK:3393Electronic

Assessing Wasion Holdings (SEHK:3393) Valuation After Upgraded 2025 Profit Guidance

Wasion Holdings (SEHK:3393) issued new earnings guidance for 2025, projecting consolidated net profit of CN¥1,000 million to CN¥1,060 million, compared with about CN¥705.61 million in 2024, citing higher sales and tighter cost controls. See our latest analysis for Wasion Holdings. The new guidance comes after a powerful run in the shares, with a 90 day share price return of 78.42% and a 1 year total shareholder return that is more than triple the initial investment. This suggests that...
SEHK:2007
SEHK:2007Real Estate

Country Garden Holdings (SEHK:2007) Valuation Check After February 2026 Contracted Sales Update

February sales announcement and what it tells you Country Garden Holdings (SEHK:2007) has released preliminary unaudited contracted sales for February 2026, reporting about RMB 2.23b in sales attributable to shareholders on roughly 0.29 million square meters of gross floor area. See our latest analysis for Country Garden Holdings. Investors have seen some short term share price strength recently, with a 1 month share price return of 10.71%. However, the 90 day share price return of 36.08% and...
SEHK:1361
SEHK:1361Luxury

A Look At 361 Degrees International (SEHK:1361) Valuation After Recent Share Price Weakness

Recent share performance and business snapshot 361 Degrees International (SEHK:1361) has drawn attention after recent share price moves, with the stock showing a 1 day return of about 1.1% decline and a past month return near 4.1% decline. Over the past 3 months, the share price reflects roughly 8.4% decline, while the 1 year total return sits around 27.8%. Looking further back, 3 year and 5 year total returns are about 65.6% and 1.9x respectively. The company reports revenue of roughly...
SEHK:3320
SEHK:3320Pharmaceuticals

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation As Board Sets Date For Results And Dividend Decision

China Resources Pharmaceutical Group (SEHK:3320) has scheduled a board meeting for 24 March 2026 to approve its audited 2025 results and consider a final dividend, a key date for investors tracking income and performance. See our latest analysis for China Resources Pharmaceutical Group. At a share price of HK$4.55, China Resources Pharmaceutical Group has seen modest short term momentum, with a 1-day share price return of 1.34% and a year to date share price return of 0.89%. However, the...
SEHK:3330
SEHK:3330Metals and Mining

Lingbao Gold Group’s Valuation After Hang Seng Index And Stock Connect Inclusions

Lingbao Gold Group (SEHK:3330) is back on investors’ radar after its H shares were confirmed for inclusion in the Hang Seng Composite Index, as well as the Shanghai Hong Kong and Shenzhen Hong Kong Stock Connect schemes. See our latest analysis for Lingbao Gold Group. The latest index and Stock Connect confirmations have arrived after a strong period for the shares, with the HK$27.74 price sitting alongside a 30 day share price return of 29.51% and a 1 year total shareholder return of...
SEHK:1405
SEHK:1405Hospitality

Is DPC Dash (SEHK:1405) Pricing In Too Much Growth After A 39% Yearly Slide?

Wondering whether DPC Dash at a last close of HK$64.55 is starting to look like value or still pricing in a lot of optimism? This article is for you. The share price has moved only modestly in the short term, with a 1.1% return over 7 days, a 2.0% decline over 30 days and a 10.6% decline year to date, while the 1 year return sits at a 38.6% decline. Recent coverage of DPC Dash has focused on its position in the quick service restaurant space in China and how investors are weighing that...
SEHK:981
SEHK:981Semiconductor

Assessing Semiconductor Manufacturing International (SEHK:981) Valuation After Recent Share Price Weakness

What recent performance hints at for Semiconductor Manufacturing International Semiconductor Manufacturing International (SEHK:981) has seen its share price move lower recently, with a 1.5% decline over the past day and deeper falls over the past week and month. Against that price pressure, the company reports annual revenue of $9,045.37m and net income of $619.867m, alongside annual revenue growth of 12.3% and net income growth of 23.7%. See our latest analysis for Semiconductor...
SEHK:6869
SEHK:6869Communications

Assessing Yangtze Optical Fibre And Cable (SEHK:6869) Valuation After MWC 2026 AI Infrastructure Showcase

Yangtze Optical Fibre And Cable Limited (SEHK:6869) is back in focus after its Mobile World Congress 2026 showcase, where it highlighted all optical solutions built around AI computing, smart mobility, and proprietary hollow core fibre. See our latest analysis for Yangtze Optical Fibre And Cable Limited. The recent MWC announcements land at a time when Yangtze Optical Fibre And Cable Limited’s share price has climbed to HK$142.2, with a 30 day share price return of 56.61% and a 90 day gain...
SEHK:6963
SEHK:6963Insurance

A Look At Sunshine Insurance Group (SEHK:6963) Valuation As Board Reviews Results And Proposed Final Dividend

Sunshine Insurance Group (SEHK:6963) has called a March 16, 2026 board meeting to review audited 2025 results and consider a final dividend. This will be a key moment for investors watching earnings quality and capital returns. See our latest analysis for Sunshine Insurance Group. The upcoming results and dividend decision come after a softer patch in the share price, with a 30 day share price return of a 13.01% decline and a year to date share price return of an 8.84% decline. However, a 1...
SEHK:1921
SEHK:1921Energy Services

Assessing Dalipal Holdings (SEHK:1921) Valuation After Guidance For A Return To Profitability

Why Dalipal Holdings (SEHK:1921) is back on investors’ radar Dalipal Holdings (SEHK:1921) has issued new earnings guidance indicating a move from a 2024 loss to at least CN¥10 million in net profit for 2025, signalling a clear shift in sentiment. See our latest analysis for Dalipal Holdings. The guidance-driven turnaround comes after a weak patch for the stock, with a 90 day share price return of a 17.57% decline and a year to date return of an 18.57% decline, although the 5 year total...
SEHK:2696
SEHK:2696Biotechs

Assessing Shanghai Henlius Biotech’s Valuation As HLX11 And HLX22 Breast Cancer Programs Gain Momentum

Why HLX11 and HLX22 are in focus for Shanghai Henlius Biotech (SEHK:2696) Shanghai Henlius Biotech (SEHK:2696) is back on investors’ radar after two breast cancer program updates, including a positive CHMP opinion in Europe for its Perjeta biosimilar HLX11 and progress in its HER2 combination study HLX22 plus HLX87 in China. See our latest analysis for Shanghai Henlius Biotech. Even after a 4.42% one day share price decline to HK$65.95, Shanghai Henlius Biotech’s 12.54% year to date share...
SEHK:1070
SEHK:1070Consumer Durables

TCL Electronics Holdings (SEHK:1070) Valuation Check After MWC 2026 Product And Technology Launches

TCL Electronics Holdings (SEHK:1070) has attracted fresh attention after using Mobile World Congress 2026 to showcase its NXTPAPER 70 Pro smartphone, new NXTPAPER AMOLED display tech, connectivity devices, CrystalClip earbuds and the conceptual Tbot kids companion. See our latest analysis for TCL Electronics Holdings. Despite the fresh product buzz from MWC 2026, TCL Electronics Holdings’ recent share price has been choppy, with a 1-day share price return of a 3.73% decline and a 30-day share...
SEHK:3698
SEHK:3698Banks

Huishang Bank (SEHK:3698) Valuation Check After Positive Profit Alert And FY2025 Outlook

Huishang Bank (SEHK:3698) has drawn fresh attention after issuing a positive profit alert and preliminary FY2025 figures. The bank highlighted higher total assets, improved profitability, and better reported asset quality metrics. See our latest analysis for Huishang Bank. The positive profit alert has arrived alongside renewed interest in the stock, with an 8.53% 1 day share price return, a 22.96% 90 day share price return, and a 65.90% 1 year total shareholder return. This suggests that...
SEHK:1757
SEHK:1757Construction

Assessing Global Chinese Business Club (SEHK:1757) Valuation After Auditor Change And Board Lot Size Reduction

Global Chinese Business Club (SEHK:1757) has drawn attention after its previous auditor resigned over a fee disagreement, and the company swiftly appointed Wilson & Partners CPA, alongside a planned reduction in Hong Kong board lot size. See our latest analysis for Global Chinese Business Club. The recent auditor change and plan to cut the Hong Kong board lot size come alongside very strong share price momentum, with a 7 day share price return of 69.5% and a 30 day share price return of...
SEHK:220
SEHK:220Food

Assessing Uni-President China Holdings (SEHK:220) Valuation After 2025 Annual Results Update

Uni-President China Holdings (SEHK:220) has released its 2025 full-year results, giving investors fresh detail on sales of CNY 31,714.31 million and net income of CNY 2,050.23 million. See our latest analysis for Uni-President China Holdings. The results release comes after a period where momentum has started to pick up, with a 1-day share price return of 3.86% and a 30-day share price return of 7.19%. Over three years, the total shareholder return of 22.04% contrasts with a 1-year total...
SEHK:6979
SEHK:6979Beverage

Assessing ZJLD Group (SEHK:6979) Valuation After Sharp 2025 Earnings Guidance Cut

ZJLD Group (SEHK:6979) has issued unaudited earnings guidance for 2025, flagging revenue of around CN¥3.55b to CN¥3.70b and profit of CN¥0.52b to CN¥0.58b, both sharply lower than 2024. See our latest analysis for ZJLD Group. The earnings guidance lands after a strong run in the shares, with a 90 day share price return of 16% and a 1 year total shareholder return of 35.19%. This suggests momentum has been positive even as expectations for 2025 are reset. At the latest share price of HK$9.28,...
SEHK:1860
SEHK:1860Media

Why Mobvista (SEHK:1860) Is Up 6.0% After Raising 2025 Revenue and Profit Guidance

Mobvista Inc. recently issued earnings guidance for 2025, projecting revenue of about US$2.03–2.06 billion and profit attributable to equity shareholders of US$54–64 million, citing stable gross margins and better operating efficiency. The company highlighted rapid growth in the mobile advertising and marketing technology industry around its core Mintegral programmatic platform as a key driver of this improved profitability outlook. We will now examine how this guidance, particularly the...
SEHK:2616
SEHK:2616Biotechs

CStone Pharmaceuticals (SEHK:2616) Valuation Check After New UK Approval For Sugemalimab In Stage III Lung Cancer

CStone Pharmaceuticals (SEHK:2616) is back on investors radar after the UK regulator granted a new indication for its cancer drug sugemalimab, extending its use in specific stage III lung cancer patients. See our latest analysis for CStone Pharmaceuticals. The MHRA decision lands at a time when CStone’s 1 month share price return of 30.91% and 90 day share price return of 18.75% suggest building momentum. However, the 1 year total shareholder return of 100.30% contrasts with a 5 year total...
SEHK:2799
SEHK:2799Capital Markets

Assessing China CITIC Financial Asset Management’s Valuation After Major Board And Committee Changes

Board reshuffle and what it might mean for investors China CITIC Financial Asset Management (SEHK:2799) has just gone through a significant board reshuffle, with three directors departing and new committee chairs and members appointed following its February 28, 2026 board meeting. See our latest analysis for China CITIC Financial Asset Management. At a share price of HK$0.81, China CITIC Financial Asset Management has had a mixed run, with a 1-day share price return of 1.25% but a 90-day...
SEHK:1177
SEHK:1177Pharmaceuticals

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After Sanofi Rovadicitinib Licensing Agreement

Sino Biopharmaceutical (SEHK:1177) has drawn fresh investor attention after signing an exclusive global license agreement with Sanofi for its JAK/ROCK inhibitor rovadicitinib, tied to upfront, milestone and royalty payments. See our latest analysis for Sino Biopharmaceutical. The Sanofi licensing news arrives at a time when Sino Biopharmaceutical’s shares trade at HK$6.13, with a 1 day share price return of 3.72% and a year to date share price return decline of 3.62%. However, a 1 year total...